SOURCE: Bollinger Report

January 20, 2012 09:00 ET

A Forward Look, the Year Ahead - Featured Research on Convergys Corporation and Bristol Myers Squibb Co.

HONG KONG--(Marketwire - Jan 20, 2012) - Today, introduced featured coverage of Convergys Corporation (NYSE: CVG) and Bristol Myers Squibb Co. (NYSE: BMY). Full research reports are available to readers at:

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Bollinger Report screened and selected Convergys Corporation for its current position within the technology industry. Convergys Corporation (Convergys) is engaged in relationship management. It operates in two segments: Customer Management and Information Management. Customer Management provides agent-assisted services, as well as self-service and technology solutions. A copy of this report featuring Convergys Corporation (NYSE: CVG) is available at:

Bollinger Report is featuring Bristol Myers Squibb Co. for its changing role within the healthcare industry. Bristol Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. To download researches and analysis on Bristol Myers Squibb Co. (NYSE: BMY) we welcome investors to visit:

About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact Information